Aptevo Therapeutics Q3 EPS $(5.19) Misses $(3.89) Estimate

Benzinga · 3d ago
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.19) per share which missed the analyst consensus estimate of $(3.89) by 33.42 percent. This is a 87.07 percent increase over losses of $(40.14) per share from the same period last year.